Vicente J, Chéchile G, Algaba F
Eur Urol. 1987;13(1-2):15-6. doi: 10.1159/000472728.
An in vivo staining test, methylene blue was applied to 50 patients with bladder tumor. 378 biopsies were performed in 85 areas stained with methylene blue and in 293 random biopsy areas. Of these samples, 56 had carcinoma in situ: 38 of these were not stained (68% false-negative) and the remaining 18 took up the stain. In the latter corresponding to 11 patients, carcinoma in situ was also shown in unstained areas examined by random biopsies. In 37 areas with urothelial dysplasia, 31 were not stained (84% false-negatives) while 6 cases (16%) took up the stain. Bladder tumors were stained in an irregular way but the intensity of the stain was related to the tumor grade. According to our experience the in vivo staining test with methylene blue cannot be used as a marker for pretumoral and tumoral lesions of the bladder.
进行了一项体内染色试验,将亚甲蓝应用于50例膀胱肿瘤患者。在85个亚甲蓝染色区域和293个随机活检区域进行了378次活检。在这些样本中,56例有原位癌:其中38例未染色(假阴性率68%),其余18例摄取了染料。在后者中,对应11例患者,随机活检检查的未染色区域也显示有原位癌。在37个有尿路上皮发育异常的区域,31个未染色(假阴性率84%),而6例(16%)摄取了染料。膀胱肿瘤染色不规则,但染色强度与肿瘤分级有关。根据我们的经验,亚甲蓝体内染色试验不能用作膀胱肿瘤前和肿瘤病变的标志物。